Originally published at: CHICAGO HOPE: New Drug Shows ‘Promise’ Against Coronavirus in Chicago Medical Trials | Sean Hannity
An experimental new drug called ‘Remdesivir’ is “showing promise” in clinical trials in Chicago against the deadly Coronavirus; sending stocks up as a possible breakthrough could be just months away.
“Some 125 people with COVID-19 — 113 with severe symptoms — were recruited by the University of Chicago Medicine into the two Gilead Phase 3 clinical trials, according to STAT. The news site obtained a recorded video discussion of the trial results,” reports Fox News.
“Partial data from an ongoing clinical trial is by definition incomplete and should never be used to draw conclusions about the safety or efficacy of a potential treatment that is under investigation,” said a spokeswoman for University of Chicago Medicine, in a statement emailed to Fox News. “In this case, information from an internal forum for research colleagues concerning work in progress was released without authorization. Drawing any conclusions at this point is premature and scientifically unsound.”
“We understand the urgent need for a COVID-19 treatment and the resulting interest in data on our investigational antiviral drug remdesivir. The totality of the data need to be analyzed in order to draw any conclusions from the trial. Anecdotal reports, while encouraging, do not provide the statistical power necessary to determine the safety and efficacy profile of remdesivir as a treatment for COVID-19. We expect the data from our Phase 3 study in patients with severe COVID-19 infection to be available at the end of this month, and additional data from other studies to become available in May. We are grateful for all of the efforts of investigators and patients participating in our studies and look forward to sharing the results from the complete dataset,” adds Fox.
Read the full report here.